Barclays PLC Bristol Myers Squibb CO Put Options Transaction History

Barclays PLC

$327 Billion
Q2 2024

Put Options

21 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $1.86 Million - $2.11 Million	38,800 New	38,800 $2.1 Million
Q2 2023 Aug 03, 2023	BUY	$63.71 - $70.74 $20.5 Million - $22.7 Million	321,000 Added 208.98%	474,600 $30.4 Million
Q1 2023 May 04, 2023	SELL	$65.71 - $74.53 $22 Million - $25 Million	-335,000 Reduced 68.56%	153,600 $10.6 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $33.5 Million - $39.6 Million	488,600 New	488,600 $35.2 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $7.33 Million - $8.54 Million	136,600 Added 128.5%	242,900 $15.1 Million
Q3 2021 Nov 09, 2021	BUY	$59.17 - $69.31 $5.92 Million - $6.93 Million	100,000 Added 1587.3%	106,300 $6.29 Million
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $24.7 Million - $27.8 Million	-417,000 Reduced 98.51%	6,300 $398,000
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $8.79 Million - $9.96 Million	152,300 Added 56.2%	423,300 $26.3 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $58.6 Million - $65 Million	-1,021,000 Reduced 79.02%	271,000 $16.3 Million
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $39.1 Million - $45.7 Million	712,900 Added 123.1%	1,292,000 $76 Million
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $1.14 Billion - $1.66 Billion	-24,559,800 Reduced 97.7%	579,100 $32.3 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $1.2 Billion - $1.57 Billion	24,443,900 Added 3517.11%	25,138,900 $1.61 Billion
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $18 Million - $21.4 Million	-421,300 Reduced 37.74%	695,000 $35.2 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $45.9 Million - $50.8 Million	-1,029,300 Reduced 47.97%	1,116,300 $50.6 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $74.2 Million - $88.5 Million	1,644,400 Added 328.09%	2,145,600 $102 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $112,148 - $145,429	-2,300 Reduced 0.46%	501,200 $26.1 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $14.7 Million - $16.6 Million	-267,100 Reduced 34.66%	503,500 $31.3 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $37.1 Million - $46.2 Million	-733,400 Reduced 48.76%	770,600 $42.6 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $54.4 Million - $62.6 Million	908,000 Added 152.35%	1,504,000 $95.1 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $617,382 - $673,104	-10,300 Reduced 1.7%	596,000 $36.5 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $33.5 Million - $38.6 Million	606,300	606,300 $38.6 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account